Abstract
Myocarditis is as an important cause of sudden cardiac death (SCD) among athletes. The incidence of SCD ascribed to myocarditis did not change after the introduction of pre-participation screening in Italy, due to the transient nature of the disease and problems in the differential diagnosis with the athlete’s heart. The arrhythmic burden and the underlying mechanisms differ between the acute and chronic setting, depending on the relative impact of acute inflammation versus post-inflammatory myocardial fibrosis. In the acute phase, ventricular arrhythmias vary from isolated ventricular ectopic beats to complex tachycardias that can lead to SCD. Atrioventricular blocks are typical of specific forms of myocarditis, and supraventricular arrhythmias may be observed in case of atrial inflammation. Athletes with acute myocarditis should be temporarily restricted from physical exercise, until complete recovery. However, ventricular tachycardia may also occur in the chronic phase in the context of post-inflammatory myocardial scar.
Similar content being viewed by others
Abbreviations
- AM:
-
Acute myocarditis
- SCD:
-
Sudden cardiac death
- EMB:
-
Endomyocardial biopsy
- LGE:
-
Late gadolinium enhancement
- CMR:
-
Cardiac magnetic resonance
- AV:
-
Atrioventricular
- LV:
-
Left ventricular
- AF:
-
Atrial fibrillation
- VF:
-
Ventricular fibrillation
- VT:
-
Ventricular tachycardia
- ICD:
-
Implantable cardioverter defibrillator
- ARVC:
-
Arrhythmogenic right ventricular cardiomyopathy
References
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., et al. (2013). Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 34(33), 2636–2648.
Caforio, A. L. P., Marcolongo, R., Basso, C., & Iliceto, S. (2015). Clinical presentation and diagnosis of myocarditis. Heart, 101(16), 1332–1344.
Baksi, A. J., Kanaganayagam, G. S., & Prasad, S. K. (2015). Arrhythmias in viral myocarditis and pericarditis. Cardiac Electrophysiology Clinics, 7(2), 269–281.
Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Bloma, N., Borggrefe, M., Camm, J., et al. (2015). 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal, 36(41), 2793–2867.
Basso, C., Carturan, E., Corrado, D., & Thiene, G. (2007). Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiology Clinics, 25(3), 423–429.
Zorzi, A., Marra, M. P., Rigato, I., De Lazzari, M., Susana, A., Niero, A., et al. (2016). Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circulation Arrhythmia and Electrophysiology, 9, e004229.
Brolinson, P., & Elliott, D. (2007). Exercise and the immune system. Clinical Journal of Sport Medicine, 26(3), 311–319.
Nieman, D. C. (1999). Nutrition, exercise, and immune system function. Clinics in Sports Medicine, 18(3), 537–548.
Nieman, D. C. (2000). Is infection risk linked to exercise workload? Medicine and Science in Sports and Exercise, 32(7), S406–S411.
Keaney, L. C., Kilding, A. E., Merien, F., & Dulson, D. K. (2018). The impact of sport related stressors on immunity and illness risk in team-sport athletes. Journal of Science and Medicine in Sport, 21(12), 1992–1999.
Moreira, A., Mortatti, A. L., Arruda, A. F. S., Freitas, C. G., De Arruda, M., & Aoki, M. S. (2014). Salivary IgA response and upper respiratory tract infection symptoms during a 21-week competitive season in young soccer players. Journal of Strength and Conditioning Research, 28(2), 467–473.
Fahlman, M. M., & Engels, H. J. (2005). Mucosal IgA and URTI in American college football players: a year longitudinal study. Medicine and Science in Sports and Exercise, 37(3), 374–380.
Zhao, G., Zhou, S., Davie, A., & Su, Q. (2012). Effects of moderate and high intensity exercise on T1/T2 balance. Exercise Immunology Review, 18, 97–113.
Gleeson, M., & Pyne, D. B. (2016). Respiratory inflammation and infections in high-performance athletes. Immunology and Cell Biology, 94(2), 124–131.
Gatmaitan, B., Chason, J., & Lerner, M. (1970). Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. The Journal of Experimental Medicine, 131(6), 1121–1136.
Kiel, R., Smith, F., Chason, J., Khatib, R., & Reyes, M. (1989). Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence. European Journal of Epidemiology, 5(3), 348–350.
Gabilondo, A., Alonso-Moran, E., Nuño-Solinis, R., Orueta, J. F., & Iruin, A. (2017). Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. Journal of Psychosomatic Research, 93, 102–109.
Lerner, A., & Wilson, F. (1973). Virus myocardiopathy. Progress in Medical Virology, 15, 63–91.
Hosenpud, J. D., Campbell, S. M., Niles, N. R., Lee, J., Mendelson, D., & Hart, M. V. (1987). Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis. Cardiovascular Research, 21(3), 217–222.
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., et al. (2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Journal of the American College of Cardiology, 42(9), 1687–1713.
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009). Sudden deaths in young competitive athletes analysis of 1866 deaths in the United States, 1980-2006. Circulation, 119(8), 1085–1092.
Harmon, K. G., Asif, I. M., Maleszewski, J. J., Owens, D. S., Prutkin, J. M., Salerno, J. C., et al. (2015). Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association Athletes. Circulation, 132(1), 10–19.
Finocchiaro, G., Papadakis, M., Robertus, J. L., Dhutia, H., Steriotis, A. K., Tome, M., et al. (2016). Etiology of sudden death in sports insights from a United Kingdom Regional Registry. Journal of the American College of Cardiology, 67(18), 2108–2115.
Thiene, G. (2018). Sudden cardiac death in the young: a genetic destiny? Clinical Medicine (London, England), 18, s17–s23.
Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, M., & Thiene, G. (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Journal of the American Medical Association, 296(13), 1593–1601.
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., et al. (2007). The role of endomyocardial biopsy in the management of cardiovascular disease. Journal of the American College of Cardiology, 50(19), 1914–1931.
Ukena, C., Mahfoud, F., Kindermann, I., Kandolf, R., Kindermann, M., & BÖhm, M. (2011). Prognostic electrocardiographic parameters in patients with suspected myocarditis. European Journal of Heart Failure, 13(4), 398–405.
De Lazzari, M., Zorzi, A., Baritussio, A., Siciliano, M., Migliore, F., Susana, A., et al. (2016). Relationship between T-wave inversion and transmural myocardial edema as evidenced by cardiac magnetic resonance in patients with clinically suspected acute myocarditis: clinical and prognostic implications. Journal of Electrocardiology, 49(4), 587–595.
Noseworthy, P. A., Weiner, R., Kim, J., Keelara, V., Wang, F., Berkstresser, B., et al. (2011). Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise training. Circulation. Arrhythmia and Electrophysiology, 4(4), 432–440.
Calore, C., Zorzi, A., Sheikh, N., Nese, A., Facci, M., Malhotra, A., et al. (2016). Electrocardiographic anterior T-wave inversion in athletes of different ethnicities: differential diagnosis between athlete’s heart and cardiomyopathy. European Heart Journal, 37(32), 2515–2527.
Zorzi, A., Calore, C., Vio, R., Pelliccia, A., & Corrado, D. (2018). Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete’s heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria. British Journal of Sports Medicine, 52(10), 667–673.
Sedaghat-Hamedani, F., Kayvanpour, E., Frankenstein, L., Mereles, D., Amr, A., Buss, S., et al. (2015). Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury - a metaanalysis of 45 studies. Clinical Chemistry, 61(10), 1246–1255.
Pinamonti, B., Alberti, E., Cigalotto, A., Dreas, L., Salvi, A., Silvestri, F., & Camerini, F. (1988). Echocardiographic findings in myocarditis. The American Journal of Cardiology, 62(4), 285–291.
Urhausen, A., Kindermann, M., Bohm, M., & Kindermann, W. (2003). Images in cardiovascular medicine. Diagnosis of myocarditis by cardiac tissue velocity imaging in an Olympic athlete. Circulation, 103(4), e21–e22.
Eichhorn, C., Bière, L., Schnell, F., Schmied, C., Wilhelm, M., Kwong, R. Y., & Gräni, C. (2019). Myocarditis in athletes is a challenge: diagnosis, risk stratification, and uncertainties. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2019.01.039.
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., et al. (2009). Cardiovascular magnetic resonance in myocarditis: a JACC white paper. Journal of the American College of Cardiology, 53(17), 1475–1487.
Caforio, A. L. P., Calabrese, F., Angelini, A., Tona, F., Vinci, A., Bottaro, S., et al. (2007). A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. European Heart Journal, 28(11), 1326–1333.
Grün, S., Schumm, J., Greulich, S., Wagner, A., Schneider, S., Bruder, O., et al. (2012). Long-term follow-up of biopsy-proven viral myocarditis. Journal of the American College of Cardiology, 59(18), 1604–1615.
Anzini, M., Merlo, M., Sabbadini, G., Barbati, G., Finocchiaro, G., Pinamonti, B., et al. (2013). Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation, 128(22), 2384–2394.
Anderson, B. R., Silver, E. S., Richmond, E., Liberman, L. (2014) Usefulness of Arrhythmias as Predictors of Death and Resource Utilization in Children With Myocarditis. The American Journal of Cardiology 114 (9):1400–1405
Begieneman, M. P. V., Emmens, R. W., Rijvers, L., Kubat, B., Paulus, W. J., Vonk, A. B. A., et al. (2016). Ventricular myocarditis coincides with atrial myocarditis in patients. Cardiovascular Pathology, 25(2), 141–148.
Habara, M., Fujieda, H., & Nakamura, Y. (2006). Images in cardiology - atrial myocarditis: a possible cause of idiopathic enlargement of bilateral atria. Heart, 92(6), 842.
Larsen, B., Maleszewski, J., Edwards, W., Cooper Jr., L., Sobonya, R., Thompson, E., et al. (2013). Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation, 127(1), 39–47.
Frustaci, A., Cameli, S., & Zeppilli, P. (1995). Biopsy evidence of atrial myocarditis in an athlete developing transient sinoatrial disease. Chest, 108(5), 1460–1462.
Schnabel, R. B., Larson, M. G., Yamamoto, J. F., Kathiresan, S., Rong, J., Levy, D., et al. (2009). Relation of multiple inflammatory biomarkers to incident atrial fibrillation. The American Journal of Cardiology, 104(1), 92–96.
Marcus, G. M., Smith, L. M., Ordovas, K., Scheinman, M. M., Kim, A. M., Badhwar, N., et al. (2010). Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm, 7(2), 149–154.
Imazio, M., & Trinchero, R. (2008). Myopericarditis: etiology, management, and prognosis. International Journal of Cardiology, 127(1), 17–26.
Haissaguerre, M., Jais, P., Shah, D., Takahashi, A., Hocini, M., Quiniou, G., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine, 339(10), 659–666.
Basso, C., Corrado, D., Rossi, L., & Thiene, G. (2001). Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation, 103(2), 269–275.
Jais, P., Haissaguerre, M., Shah, D., Chouairi, S., Gencel, L., Hocini, M., & Clementy, J. (1997). A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 95(3), 572–576.
Haissaguerre, M., Jais, P., Shah, D., Garrigue, S., Takahashi, A., Lervegne, T., et al. (2000). Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation, 101(12), 1409–1417.
Haissaguerre, M., Shah, D., Jais, P., Hocini, M., Yamane, T., Deisenhofer, I., et al. (2000). Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation, 102(20), 2463–2465.
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., et al. (2018). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). European Heart Journal, 39(16), 1442–1445.
Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997). Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 96(4), 1180–1184.
Cooper, L. T., Berry, G. J., & Shabetai, R. (1997). Idiopathic giant-cell myocarditis — natural history and treatment. The New England Journal of Medicine, 336(26), 1860–1866.
Ekstrom, K., Lehtonen, J., Kandolin, R., Raisanen-Sokolowski, A., Salmenkivi, K., & Kupari, M. (2016). Long-term outcome and its predictors in giant cell myocarditis. European Journal of Heart Failure, 18(12), 1452–1458.
Hamzeh, N., Steckman, D. A., Sauer, W. H., & Judson, M. A. (2015). Pathophysiology and clinical management of cardiac sarcoidosis. Nature Reviews. Cardiology, 12(5), 278–288.
Baughman, R. P., & Grutters, J. C. (2015). New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches. The Lancet Respiratory Medicine, 3(10), 813–822.
Facco, M., Cabrelle, A., Teramo, A., Olivieri, V., Gnoato, M., Teolato, S., et al. (2011). Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax, 66(2), 144–150.
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., et al. (2017). Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. European Heart Journal, 38(35), 2649–2662.
McAlister, H. F., Klementowicz, P. T., Andrews, C., Fisher, J. D., Feld, M., & Furman, S. (1989). Lyme carditis: an important cause of reversible heart block. Annals of Internal Medicine, 110(5), 339–345.
Celik, T., Selimov, N., Vekilova, A., Kursaklioglu, H., Iyisoy, A., Kilic, S., & Isik, E. (2006). Prognostic significance of electrocardiographic abnormalities in diphtheritic myocarditis after hospital discharge: a long-term follow-up study. Annals of Noninvasive Electrocardiology, 11(1), 28–33.
Rassi Jr., A., Rassi, A., Little, W. C., Xavier, S. S., Rassi, S. G., Rassi, A. G., et al. (2006). Development and validation of a risk score for predicting death in Chagas’ heart disease. The New England Journal of Medicine, 355(8), 799–808.
Punja, M., Mark, D. G., McCoy, J. V., Javan, R., Pines, J. M., & Brady, W. (2010). Electrocardiographic manifestations of cardiac infectious-inflammatory disorders. The American Journal of Emergency Medicine, 28(3), 364–377.
Yilmaz, A., Mahrholdt, H., Athanasiadis, A., Vogelsberg, H., Meinhardt, G., Voehringer, M., et al. (2008). Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart, 94(11), 1456–1463.
Frustaci, A., Verardo, R., Caldarulo, M., Acconcia, M. C., Russo, M. A., & Chimenti, C. (2007). Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. European Heart Journal, 28(6), 733–740.
Basso, C., Ronco, F., Marcus, F., Abudureheman, A., Rizzo, S., Frigo, A. C., et al. (2008). Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. European Heart Journal, 29(22), 2760–2771.
Chimenti, C., Pieroni, M., Maseri, A., & Frustaci, A. (2004). Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. Journal of the American College of Cardiology, 43(12), 2305–2313.
Bowles, N. E., Ni, J., Marcus, F., & Towbin, J. A. (2002). The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 39(5), 892–895.
Rademakers, F. E., Rogers, W. J., Guier, W. H., Hutchins, G. M., Siu, C. O., Weisfeldt, M. L., et al. (1994). Relation of regional cross-fiber shortening to wall thickening in the intact heart: three-dimensional strain analysis by NMR tagging. Circulation, 89(3), 1174–1182.
Möhlenkamp, S., Lehmann, N., Breuckmann, F., Bröcker-Preuss, M., Nassenstein, K., Halle, M., et al. (2008). Running: the risk of coronary events - prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. European Heart Journal, 29(15), 1903–1910.
Breuckmann, F., Möhlenkamp, S., Nassenstein, K., Lehmann, N., Ladd, S., Schmermund, A., et al. (2009). Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology, 251(1), 50–57.
Bohm, P., Schneider, G., Linneweber, L., Rentzsch, A., Krämer, N., Abdul-Khaliq, H., et al. (2016). Right and left ventricular function and mass in male elite master athletes: a controlled contrast-enhanced cardiovascular magnetic resonance study. Circulation, 133(20), 1927–1935.
Sanchis-Gomar, F., López-Ramón, M., Alis, R., Garatachea, N., Pareja-Galeano, H., Santos-Lozano, A., et al. (2016). No evidence of adverse cardiac remodeling in former elite endurance athletes. International Journal of Cardiology, 222, 171–177.
Merghani, A., Maestrini, V., Rosmini, S., Cox, A. T., Dhutia, H., Bastiaenan, R., et al. (2017). Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation, 136(2), 126–137.
Tahir, E., Starekova, J., Muellerleile, K., von Stritzky, A., Münch, J., Avanesov, M., et al. (2018). Myocardial fibrosis in competitive triathletes detected by contrast-enhanced CMR correlates with exercise-induced hypertension and competition history. JACC: Cardiovascular Imaging, 11(9), 1260–1270.
Mousavi, N., Czarnecki, A., Kumar, K., Fallah-Rad, N., Lytwyn, M., Han, S. Y., et al. (2009). Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. The American Journal of Cardiology, 103(10), 1467–1472.
O’Hanlon, R., Wilson, M., Wage, R., Smith, G., Alpendurada, F., Wong, J., et al. (2010). Troponin release following endurance exercise: is inflammation the cause? A cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, 12, 38.
Oomah, S. R., Mousavi, N., Bhullar, N., Kumar, K., Walker, J. R., Lytwyn, M., et al. (2011). The role of three-dimensional echocardiography in the assessment of right ventricular dysfunction after a half marathon: comparison with cardiac magnetic resonance imaging. Journal of the American Society of Echocardiography, 24(2), 207–213.
Wilson, M., O’Hanlon, R., Prasad, S., Deighan, A., MacMillan, P., Oxborough, D., et al. (2011). Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. Journal of Applied Physiology, 110(6), 1622–1626.
La Gerche, A., Burns, A. T., Mooney, D. J., Inder, W. J., Taylor, A. J., Bogaert, J., et al. (2012). Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. European Heart Journal, 33(8), 998–1006.
Erz, G., Mangold, S., Franzen, E., Claussen, C. D., Niess, A. M., Burgstahler, C., & Kramer, U. (2013). Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging. The International Journal of Cardiovascular Imaging, 29(2), 325–334.
Mangold, S., Kramer, U., Franzen, E., Erz, G., Bretschneider, C., Seeger, A., et al. (2013). Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging. Rofo, 185(12), 1167–1174.
Franzen, E., Mangold, S., Erz, G., Claussen, C. D., Niess, A. M., Kramer, U., & Burgstahler, C. (2013). Comparison of morphological and functional adaptations of the heart in highly trained triathletes and long-distance runners using cardiac magnetic resonance imaging. Heart and Vessels, 28(5), 626–631.
Corrado, D., Van Tintelen, J., Mckenna, W., Hauer, R., Anastasakis, A., Asimaki, A., et al. (2019). Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. European Heart Journal in press.
Pelliccia, A., Corrado, D., Bjã¸rnstad, H. H., Panhuyzen-Goedkoop, N., Urhausen, A., Carre, F., et al. (2006). Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. European Journal of Preventive Cardiology, 13(6), 876–885.
Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005). Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. Journal of the American College of Cardiology, 45(8), 1340–1345.
Pelliccia, A., Solberg, E. E., Papadakis, M., Adami, P. E., Biffi, A., Caselli, S., et al. (2019). Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). European Heart Journal, 40(1), 19–33.
Maron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes, N. A. M., et al. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology, 66(21), 2362–2371.
Zorzi, A., Susana, A., De Lazzari, M., Migliore, F., Vescovo, G., Scarpa, D., et al. (2018). Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest. Heart Rhythm, 15(7), 1031–1041.
Zorzi, A., Rigato, I., Pilichou, K., Marra, M. P., Migliore, F., Mazzotti, E., et al. (2016). Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy. Europace, 18(7), 1086–1094.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Associate Editor Domingo A. Pascual-Figal oversaw the review of this article
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vio, R., Zorzi, A. & Corrado, D. Myocarditis in the Athlete: Arrhythmogenic Substrates, Clinical Manifestations, Management, and Eligibility Decisions. J. of Cardiovasc. Trans. Res. 13, 284–295 (2020). https://doi.org/10.1007/s12265-020-09996-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-020-09996-1